Relative paradigms between autoantibodies in lupus and autoantibodies in cancer
- 12 September 2003
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 134 (2) , 169-177
- https://doi.org/10.1046/j.1365-2249.2003.02259.x
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- C‐MYC and IGF‐II mRNA‐binding protein (CRD‐BP/IMP‐1) in benign and malignant mesenchymal tumorsInternational Journal of Cancer, 2001
- Serum Anti-p53 Antibodies and Prognosis of Patients With Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1997
- Anti-p53 Antibodies in Sera of Workers Occupationally Exposed to Vinyl ChlorideJNCI Journal of the National Cancer Institute, 1995
- Antibodies Against Autologous Tumor Cell Proteins in Patients With Small-Cell Lung Cancer: Association With Improved SurvivalJNCI Journal of the National Cancer Institute, 1993
- Human autoantibody-reactive epitopes of SS-B/La are highly conserved in comparison with epitopes recognized by murine monoclonal antibodies.The Journal of Experimental Medicine, 1987
- Cyclin (PCNA, auxiliary protein of DNA polymerase δ) is a central component of the pathway(s) leading to DNA replication and cell divisionFEBS Letters, 1987
- Autoantibody to RNA polymerase I in scleroderma sera.Journal of Clinical Investigation, 1987
- Identity of the proliferating cell nuclear antigen and cyclinNature, 1984
- Identification of a nuclear and of a cytoplasmic polypeptide whose relative proportions are sensitive to changes in the rate of cell proliferationExperimental Cell Research, 1981
- A nuclear antigen associated with cell proliferation and blast transformation.The Journal of Experimental Medicine, 1981